Chronic estrogen replacement inhibits aortic intimal hyperplasia independent of serum lipids

Journal of Cardiac Surgery

Volumn 12, Issue 4, 1997, Pages 228-234

  Selzman, Craig H ^a   Turner, A Simon ^b   Johnson, Sylene M ^a   Cain, Brian S ^b   Harken, Alden H ^a   Whitehill, Thomas A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ANIMAL EXPERIMENT; AORTA ATHEROSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; NONHUMAN; SHEEP; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031433292     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.1997.tb00130.x     Document Type: Article

References (27)

1. Barrett-Connor E, Bush TL: Estrogen and coronary heart disease in women. JAMA 1991;265: 1861-1867.
2. Grady D, Rubin SM, Petitti DB, et al: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117:1016-1037.
3. Walsh BW, Schiff I, Rosner B, et al: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-1204.
4. Bush TL, Barrett-Connor E, Cowan LD, et al: Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-1109.
5. Farhat MY, Lavigne MC, Ramwell PW: The vascular protective effects of estrogens. FASEB J 1996;10:615-624.
6. Stehbens WE: An appraisal of cholesterol feeding in experimental atherogenesis. Prog Cardiovasc Dis 1986;39:107-128.
7. Karsch FJ, Dierschke DJ, Weick RF, et al: Positive and negative feedback control by estrogen of luteinizing hormone secretion in the rhesus monkey. Endocrinology 1973;92:799-804.
8. Foegh ML, Khirabadi BS, Nakanishi T, et al: Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc 1987;19:90-95.
9. Cheng LP, Kuwahara M, Jacobsson J, et al: Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation 1991;52:967-972.
10. Foegh ML, Asotra S, Howell MH, et al: Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 1994;19:722-726.
11. Sullivan TR, Karas RH, Aronovitz M, et al: Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995;96: 2482-2488.
12. Pick R, Stamler J, Rodbard S, et al: The inhibition of coronary atheromatosis in cholesterol-fed chicks receiving estrogens. Circulation 1951;4: 468.
13. Kushwaha RS, Hazzard WR: Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism 1981;30:359-366.
14. Henrikkson P, Stamberger M, Eriksson M, et al: Oestrogen-induced changes in lipoprotein metabolism: Role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest 1989;19:395-403.
15. Adams MR, Kaplan JR, Manuck SB, et al: Inhibition of coronary artery atherosclerosis by 17-estradiol in ovariectomized monkeys - lack of an effect of added progesterone. Arterioscler 1990; 10:1051-1057.
16. Sulistiyani, Adelman SJ, Chandrasekaran A, et al: Effect of 17-dihydroequilin sulfate, a conjugated equine estrogen, and ethynylestradiol on atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1995;15:837-846.
17. Holm P, Andersen HO, Nordestgaard BG, et al: Effect of estrogen replacement therapy on development of experimental arteriosclerosis: A study in transplanted and balloon-injured rabbit aortas. Atherosclerosis 1995;115:191-200.
18. Lobo RA: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab 1991;73:925-930.
19. Williams JK, Kim TD, Adams MR, et al: Effects of estrogen on cardiovascular responses of premenopausal monkeys. J Pharmacol Exp Therap 1994;271:671-676.
20. Krasinski KL, Silver M, Asahara T, et al: Estrogen replacement therapy accelerates reendothelializtion of balloon-injured arteries in ovariectomized rat model. Circulation 1996;94:1-150.
21. Herrington DM, Braden GA, Williams HK, et al: Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol 1994;73:951-952.
22. Caulin-Glaser T, Watson CA, Pardi R, et al: Effects of 17-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996;98:36-42.
23. Hayashi T, Yamada K, Esake T, et al: Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995;214:847-855.
24. Jiang C, Sarrel PM, Poole-Wilson PA, et al: Acute effect of 17-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 1992;263:H271-H275.
25. Mikkola T, Turunen P, Avela K, et al: 17-Estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab 1995;80:1832-1836.
26. Fischer GM, Swain ML: Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis 1985;54:177-185.
27. Espinosa E, Oemar BS, Luscher TF: 17-estradiol and smooth muscle cell proliferation in aortic cells of male and female rats. Biochem Biophys Res Commun 1996;221:8-14.